Acyclovir plus CMV immunoglobulin prophylaxis and early therapy with ganciclovir are effective and safe in CMV high-risk renal transplant pediatric recipients

✍ Scribed by F. Ginevri; G. Losurdo; I. Fontana; A. M. Rabagliati; L. Bonatto; R. Valente; P. Venzano; A. Nocera; G.C. Basile; U. Valente; R. Gusmano

• Book ID: 110915583
• Publisher: Springer
• Year: 1998
• Tongue: English
• Weight: 507 KB
• Volume: 11
• Category: Article
• ISSN: 0934-0874
• DOI: 10.1111/j.1432-2277.1998.tb01096.x